Company page

Affymax Inc

Affymax Inc (ticker: AFFY) is a public company based in the United States, with a market capitalization of approximately $48.7 million. The company is focused on developing innovative therapies for patients with serious medical conditions. Affymax aims to improve patient outcomes through its research and development efforts.